September 18th, 2014, Vancouver, BC – Supreme Pharmaceuticals Inc. (the “Company”) (“SL” – CSE) is pleased to announce that it has engaged Merriman Capital, Inc. (“Merriman”), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX:MERR) as its Capital Markets Advisor. As part of the engagement, Merriman will act as Principal American Liaison (PAL) to Supreme in connection with Supreme’s US operations.
Merriman’s Capital Markets Advisory Group clients benefit from corporate brokerage services, access to unique capital solutions, and a range of related services intended to help unique public and private emerging growth companies accomplish their capital markets goals.
“We welcome Supreme to our platform of Capital Markets Advisory clients,” commented Douglas Rogers, Managing Director and Head of the Capital Markets Advisory Group at Merriman. Mr. Rogers continued, “Supreme has a unique market opportunity, executing its vertically integrated full suite of services for the medicinal marijuana industry within Canada.”
About Merriman Capital, Inc.
Merriman is a full service investment bank and broker-dealer that facilitates efficient capital formation through a proprietary digital network, and offers Capital Markets Advisory and comprehensive Corporate Brokerage services for public and private companies. The firm also provides equity and options execution services for sophisticated investors and differentiated research for high growth companies. Merriman Capital, Inc. is a wholly owned brokerage subsidiary of Merriman Holdings, Inc. (OTCQX:MERR) and is a leading advisory firm for publicly traded, high-growth companies.